| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | 487 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
| 02.12.24 | Astorg Completes Take Private of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health | 411 | Business Wire | Establishing a Global Leader in Assisted Reproductive Technology Consumables and Equipment
Hamilton Thorne delists from the Toronto Stock Exchange Cook Medical Reproductive Health ("Cook... ► Artikel lesen | |
| HAMILTON THORNE Aktie jetzt für 0€ handeln | |||||
| 29.11.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Closing of Going Private Transaction | 729 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 29, 2024) - Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments... ► Artikel lesen | |
| 14.11.24 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2024 | 314 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables,... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 285,50 | -0,92 % | UnitedHealth wieder auf dem absteigenden Ast - Cigna crasht nach Warnung | Der US-Krankenversicherungsmarkt bleibt in einem sehr schwierigen Fahrwasser - darüber hinweg kann auch die leicht angehobene Gewinnprognose von UnitedHealth in dieser Woche nicht täuschen. Mit Cigna... ► Artikel lesen | |
| MEDTRONIC | 78,19 | -0,74 % | Medtronic: From Curse to Career | Cardiac mapper turned treatment of his own heart condition into a new career NORTHAMPTON, MA / ACCESS Newswire / November 3, 2025 / David Stalls thought the dangerous heart rhythm problem that plagued... ► Artikel lesen | |
| INTUITIVE SURGICAL | 473,00 | +0,77 % | IBD Stock Of The Day: Why Robotics Giant Intuitive Surgical Has Surged | ||
| TELADOC HEALTH | 7,045 | +1,28 % | How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell? | ||
| SERNOVA BIOTHERAPEUTICS | 0,094 | -0,53 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Announces Voting Results from Special Meeting of Stockholders / Evofem Shareholders Did Not Approve the Merger with Aditxt | -- Evofem Shareholders Did Not Approve the Merger with Aditxt --
-- Evofem Pivots to Target National Listing for Stock, Growth Capital to Catalyze Net Sales... ► Artikel lesen | |
| HCA HEALTHCARE | 406,60 | -1,00 % | HCA Healthcare, Inc. - 8-K, Current Report | ||
| LANTHEUS | 50,000 | -0,52 % | Uncovering Potential: Lantheus Holdings' Earnings Preview | ||
| ENVISTA | 17,300 | -1,70 % | Envista Holdings Corporation: Envista Reports Third Quarter 2025 Results | BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025."This was another strong quarter... ► Artikel lesen | |
| CAREDX | 14,395 | +13,93 % | CareDx raises 2025 revenue guidance to $372M-$376M with robust RCM gains and new product launches | ||
| GT BIOPHARMA | 0,535 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies | The Company is well on track with Phase 1 enrollment now that both patients in Cohort 3 have successfully initiated treatment with no evidence of dose-limiting toxicities or tolerability concerns... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results | Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA
HENDERSON, Nev., Sept. 18, 2025 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | CARMAT Provides an Update on the Ongoing Receivership Procedure | A takeover bid within the context of a sales plan has been received by the judiciary administrator
Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced... ► Artikel lesen | |
| CHEMOMETEC | 96,55 | -4,78 % | Chemometec A/S: Upgrade of guidance | ANNOUNCEMENT NO. 295 28 October 2025 Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive... ► Artikel lesen |